214 related articles for article (PubMed ID: 12396921)
1. Call-tracking data and the public health response to bioterrorism-related anthrax.
Mott JA; Treadwell TA; Hennessy TW; Rosenberg PA; Wolfe MI; Brown CM; Butler JC
Emerg Infect Dis; 2002 Oct; 8(10):1088-92. PubMed ID: 12396921
[TBL] [Abstract][Full Text] [Related]
2. Bioterrorism-related anthrax: international response by the Centers for Disease Control and Prevention.
Polyak CS; Macy JT; Irizarry-De La Cruz M; Lai JE; McAuliffe JF; Popovic T; Pillai SP; Mintz ED;
Emerg Infect Dis; 2002 Oct; 8(10):1056-9. PubMed ID: 12396915
[TBL] [Abstract][Full Text] [Related]
3. Update: Investigation of bioterrorism-related anthrax, 2001.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(45):1008-10. PubMed ID: 11724158
[TBL] [Abstract][Full Text] [Related]
4. Anthrax bioterrorism: lessons learned and future directions.
Hughes JM; Gerberding JL
Emerg Infect Dis; 2002 Oct; 8(10):1013-4. PubMed ID: 12396907
[No Abstract] [Full Text] [Related]
5. Our first line of defense against bioterrorism part 2.
Simpson RL
Nurs Manage; 2002 May; 33(5):10, 11. PubMed ID: 12006878
[TBL] [Abstract][Full Text] [Related]
6. Coordinated response to reports of possible anthrax contamination, Idaho, 2001.
Tengelsen L; Hudson R; Barnes S; Hahn C
Emerg Infect Dis; 2002 Oct; 8(10):1093-5. PubMed ID: 12396922
[TBL] [Abstract][Full Text] [Related]
7. No evidence of a mild form of inhalational Bacillus anthracis infection during a bioterrorism-related inhalational anthrax outbreak in Washington, D.C., in 2001.
Baggett HC; Rhodes JC; Fridkin SK; Quinn CP; Hageman JC; Friedman CR; Dykewicz CA; Semenova VA; Romero-Steiner S; Elie CM; Jernigan JA
Clin Infect Dis; 2005 Oct; 41(7):991-7. PubMed ID: 16142664
[TBL] [Abstract][Full Text] [Related]
8. Update: Investigation of bioterrorism-related anthrax and adverse events from antimicrobial prophylaxis.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(44):973-6. PubMed ID: 11724150
[TBL] [Abstract][Full Text] [Related]
9. Update: Investigation of bioterrorism-related anthrax and interim guidelines for clinical evaluation of persons with possible anthrax.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(43):941-8. PubMed ID: 11708591
[TBL] [Abstract][Full Text] [Related]
10. Inhalational anthrax due to bioterrorism: would current Centers for Disease Control and Prevention guidelines have identified the 11 patients with inhalational anthrax from October through November 2001?
Mayer TA; Morrison A; Bersoff-Matcha S; Druckenbrod G; Murphy C; Howell J; Hanfling D; Cates R; Pauze D; Earls J
Clin Infect Dis; 2003 May; 36(10):1275-83. PubMed ID: 12746773
[TBL] [Abstract][Full Text] [Related]
11. Responding to a bioterrorist attack: environmental investigation of anthrax in New Jersey.
Valiante DJ; Schill DP; Bresnitz EA; Burr GA; Mead KR
Appl Occup Environ Hyg; 2003 Oct; 18(10):780-5. PubMed ID: 12959889
[TBL] [Abstract][Full Text] [Related]
12. Increased US prescription trends associated with the CDC Bacillus anthracis antimicrobial postexposure prophylaxis campaign.
Shaffer D; Armstrong G; Higgins K; Honig P; Coyne P; Boxwell D; Beitz J; Leissa B; Murphy D
Pharmacoepidemiol Drug Saf; 2003; 12(3):177-82. PubMed ID: 12733470
[TBL] [Abstract][Full Text] [Related]
13. Uncertain science and certain deadlines: CDC responses to the media during the anthrax attacks of 2001.
Robinson SJ; Newstetter WC
J Health Commun; 2003; 8 Suppl 1():17-34; discussion 148-51. PubMed ID: 14692570
[TBL] [Abstract][Full Text] [Related]
14. Serious adverse events among participants in the Centers for Disease Control and Prevention's Anthrax Vaccine and Antimicrobial Availability Program for persons at risk for bioterrorism-related inhalational anthrax.
Tierney BC; Martin SW; Franzke LH; Marano N; Reissman DB; Louchart RD; Goff JA; Rosenstein NE; Sever JL; McNeil MM;
Clin Infect Dis; 2003 Oct; 37(7):905-11. PubMed ID: 13130401
[TBL] [Abstract][Full Text] [Related]
15. Calls about anthrax to the Texas Poison Center Network in relation to the anthrax bioterrorism attack in 2001.
Forrester MB; Stanley SK
Vet Hum Toxicol; 2003 Oct; 45(5):247-8. PubMed ID: 14513892
[TBL] [Abstract][Full Text] [Related]
16. Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings.
Jernigan DB; Raghunathan PL; Bell BP; Brechner R; Bresnitz EA; Butler JC; Cetron M; Cohen M; Doyle T; Fischer M; Greene C; Griffith KS; Guarner J; Hadler JL; Hayslett JA; Meyer R; Petersen LR; Phillips M; Pinner R; Popovic T; Quinn CP; Reefhuis J; Reissman D; Rosenstein N; Schuchat A; Shieh WJ; Siegal L; Swerdlow DL; Tenover FC; Traeger M; Ward JW; Weisfuse I; Wiersma S; Yeskey K; Zaki S; Ashford DA; Perkins BA; Ostroff S; Hughes J; Fleming D; Koplan JP; Gerberding JL;
Emerg Infect Dis; 2002 Oct; 8(10):1019-28. PubMed ID: 12396909
[TBL] [Abstract][Full Text] [Related]
17. Update: investigation of bioterrorism-related inhalational anthrax--Connecticut, 2001.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(47):1049-51. PubMed ID: 11808925
[TBL] [Abstract][Full Text] [Related]
18. Surveillance for anthrax cases associated with contaminated letters, New Jersey, Delaware, and Pennsylvania, 2001.
Tan CG; Sandhu HS; Crawford DC; Redd SC; Beach MJ; Buehler JW; Bresnitz EA; Pinner RW; Bell BP; ;
Emerg Infect Dis; 2002 Oct; 8(10):1073-7. PubMed ID: 12396918
[TBL] [Abstract][Full Text] [Related]
19. Communication lessons learned in the Emergency Operations Center during CDC's anthrax response: a commentary.
Vanderford ML
J Health Commun; 2003; 8 Suppl 1():11-2. PubMed ID: 14692567
[No Abstract] [Full Text] [Related]
20. Public health in the time of bioterrorism.
Perkins BA; Popovic T; Yeskey K
Emerg Infect Dis; 2002 Oct; 8(10):1015-8. PubMed ID: 12396908
[No Abstract] [Full Text] [Related]
[Next] [New Search]
